Pterostilbene

Pterostilbene

SCHEMBL3476941

C(=C/c1ccccc1)\c1ccccc1.COc1cc(/C=C/c2ccc(O)cc2)cc(OC)c1

nearest known ligand 0.86

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 5/20 0.86
CYP1A1 P04798 4/20 0.86
PTGS2 P35354 4/20 0.86
CYP1B1 Q16678 4/20 0.86
ALOX5 P09917 4/20 0.86
ABL1 P00519 4/20 0.86
BCR P11274 4/20 0.86
TTR P02766 3/20 0.86
KDM4E B2RXH2 3/20 0.86
ABCB1 P08183 3/20 0.86
MEN1 O00255 2/20 0.86
MAPT P10636 2/20 0.86
KMT2A Q03164 2/20 0.86
PTGS1 P23219 2/20 0.86
NPC1 O15118 1/20 0.86
GAA P10253 1/20 0.86
MAPK1 P28482 1/20 0.86
RAB9A P51151 1/20 0.86
GFER P55789 1/20 0.86
HDAC6 Q9UBN7 1/20 0.86

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pterostilbene SCHEMBL3476943 1.00 NQO2 (0.86) NQO2CYP1A1PTGS2CYP1B1ALOX5
Pterostilbene SCHEMBL28222684 0.93 CYP1A1 (1.00) NQO2CYP1A1PTGS2CYP1B1ALOX5
Pterostilbene SCHEMBL3545782 0.93 CYP1A1 (1.00) NQO2CYP1A1PTGS2CYP1B1ALOX5
Pterostilbene SCHEMBL563218 0.93 CYP1A1 (1.00) NQO2CYP1A1PTGS2CYP1B1ALOX5
Pterostilbene SCHEMBL20063 0.93 CYP1A1 (1.00) NQO2CYP1A1PTGS2CYP1B1ALOX5
Pinosylvin Methyl Ether SCHEMBL9419826 0.89 KDM4E (1.00) NQO2CYP1A1PTGS2CYP1B1ALOX5
Pinosylvin Methyl Ether SCHEMBL1650248 0.89 KDM4E (1.00) NQO2CYP1A1PTGS2CYP1B1ALOX5
Pinosylvin Methyl Ether SCHEMBL29928865 0.89 KDM4E (1.00) NQO2CYP1A1PTGS2CYP1B1ALOX5
Pinosylvin Methyl Ether SCHEMBL30334927 0.89 KDM4E (1.00) NQO2CYP1A1PTGS2CYP1B1ALOX5
Pinosylvin Methyl Ether SCHEMBL1650247 0.89 KDM4E (1.00) NQO2CYP1A1PTGS2CYP1B1ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010111719-A2 MELANOGENESIS INHIBITION BY 3, 5-DIMETHOXY-4'-HYDROXYSTILBENES AND COSMECEUTICAL COMPOSITIONS THEREOF SAMI LABS LIMITED (IN) 2010-09-30 WO disclosed
US-20100240767-A1 Melanogenesis inhibitiuon by 3,5-dimethoxy-4'-hydroxystilbenes and cosmeceutical compositions thereof SAMI LABS LTD (IN) 2010-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240767-A1 Melanogenesis inhibitiuon by 3,5-dimethoxy-4'-hydroxystilbenes and cosmeceutical compositions thereof TYR, MC1R, MITF NQO2 532/4885CYP1A1 620/4885PTGS2 472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.